DekaBank Deutsche Girozentrale Sells 157,364 Shares of Afya Limited (NASDAQ:AFYA)

DekaBank Deutsche Girozentrale cut its stake in shares of Afya Limited (NASDAQ:AFYA) by 57.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 117,086 shares of the company’s stock after selling 157,364 shares during the period. DekaBank Deutsche Girozentrale owned 0.12% of Afya worth $2,431,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Daiwa Securities Group Inc. grew its holdings in shares of Afya by 32.6% during the third quarter. Daiwa Securities Group Inc. now owns 4,145 shares of the company’s stock worth $65,000 after purchasing an additional 1,020 shares in the last quarter. UBS Group AG grew its holdings in shares of Afya by 48.4% during the fourth quarter. UBS Group AG now owns 3,151 shares of the company’s stock worth $49,000 after purchasing an additional 1,027 shares in the last quarter. State Street Corp grew its holdings in shares of Afya by 1.1% during the third quarter. State Street Corp now owns 95,845 shares of the company’s stock worth $1,300,000 after purchasing an additional 1,034 shares in the last quarter. Lazard Asset Management LLC grew its holdings in shares of Afya by 12.7% during the third quarter. Lazard Asset Management LLC now owns 16,312 shares of the company’s stock worth $257,000 after purchasing an additional 1,840 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in Afya by 138.9% in the fourth quarter. Bank of America Corp DE now owns 3,178 shares of the company’s stock worth $50,000 after buying an additional 1,848 shares in the last quarter. 88.02% of the stock is currently owned by institutional investors.

Afya Stock Performance

Shares of AFYA stock opened at $16.96 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.14 and a current ratio of 1.14. Afya Limited has a fifty-two week low of $10.72 and a fifty-two week high of $22.48. The stock has a 50 day moving average price of $19.81 and a two-hundred day moving average price of $19.30. The company has a market capitalization of $1.59 billion, a P/E ratio of 19.72, a PEG ratio of 0.56 and a beta of 0.97.

Afya (NASDAQ:AFYA) last announced its quarterly earnings data on Thursday, March 14th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.02. Afya had a return on equity of 15.88% and a net margin of 13.54%. The firm had revenue of $147.35 million during the quarter, compared to the consensus estimate of $141.83 million. Analysts expect that Afya Limited will post 1.54 earnings per share for the current year.

Wall Street Analyst Weigh In

AFYA has been the subject of several research reports. Citigroup initiated coverage on Afya in a research note on Monday, January 29th. They issued a “neutral” rating and a $23.00 target price for the company. Morgan Stanley lowered Afya from an “overweight” rating to an “equal weight” rating and upped their target price for the stock from $20.50 to $23.00 in a research note on Monday, January 22nd.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.